Whitney Ijem Score: 27
Analyst at
Canaccord Genuity
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+26.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
41%
7 W / 10 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
42%
5 W / 7 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
17%
2 W / 10 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 11 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
43%
6 W / 8 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
38%
6 W / 10 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Apr 10, 2026 |
Pharming Group N.V. - ADR
PHAR
|
BUY |
$37.00
Est. +111%
|
$17.50 | $18.41 |
Pending
|
$12.82
-26.8%
|
| Feb 26, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$104.00
Est. +73%
|
$60.26 | $63.22 |
Pending
|
$55.65
-7.7%
|
| Dec 19, 2025 |
Fractyl Health Inc.
GUTS
|
BUY |
$8.00
Est. +254%
|
$2.26 | $2.43 |
Pending
|
$0.85
-62.4%
|
| Dec 16, 2025 |
Palvella Therapeutics, Inc.
PVLA
|
BUY |
$204.00
Est. +131%
|
$88.42 | $151.18 |
Pending
|
$108.81
+23.1%
|
| Dec 12, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$141.00
Est. +20%
|
$117.52 | $119.58 |
Pending
|
$89.70
-23.7%
|
| May 16, 2025 |
Palvella Therapeutics, Inc.
PVLA
|
BUY |
$52.00
Est. +136%
|
$22.05 | $151.18 |
Target Met
|
$108.81
+393.5%
|
| Nov 11, 2024 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$74.00
Est. +2350%
|
$3.02 | $24.08 |
Miss
|
$7.33
+142.7%
|
| Nov 11, 2024 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$39.00
Est. +128%
|
$17.09 | $17.83 |
Miss
|
$2.86
-83.3%
|
| Oct 24, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$336.00
Est. +14%
|
$294.87 | $495.55 |
Target Met
|
$287.80
-2.4%
|
| Oct 22, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$361.00
Est. +24%
|
$478.09 | $362.50 (Low) |
Bullseye Hit (±1%)
|
$450.69
+5.7%
|
| Oct 01, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$366.00
Est. +34%
|
$273.69 | $484.21 |
Target Met
|
$287.80
+5.2%
|
| Sep 18, 2024 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$38.00
Est. +74%
|
$21.80 | $22.00 |
Miss
|
$2.86
-86.9%
|
| Aug 06, 2024 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$72.00
Est. +2150%
|
$3.20 | $25.88 |
Miss
|
$7.33
+129.1%
|
| Aug 06, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$93.00
Est. +16%
|
$80.47 | $94.85 |
Precision Hit (±3%)
|
$55.65
-30.8%
|
| Jul 08, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$357.00
Est. +41%
|
$253.86 | $333.70 |
Miss
|
$287.80
+13.4%
|
| May 31, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$111.00
Est. +187%
|
$38.65 | $60.37 |
Miss
|
$25.38
-34.3%
|
| May 10, 2024 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$86.00
Est. +2145%
|
$3.83 | $25.88 |
Miss
|
$7.33
+91.4%
|
Pharming Group N.V. - ADR
PHAR
Apr 10, 2026
Signal & Target
BUY
$37.00
Start Price
$17.50
Best Price (1Y)
$18.41
Current Price
$12.82
Return
-26.8%
Signal & Target
BUY
$104.00
Start Price
$60.26
Best Price (1Y)
$63.22
Current Price
$55.65
Return
-7.7%
Fractyl Health Inc.
GUTS
Dec 19, 2025
Signal & Target
BUY
$8.00
Start Price
$2.26
Best Price (1Y)
$2.43
Current Price
$0.85
Return
-62.4%
Palvella Therapeutics, Inc.
PVLA
Dec 16, 2025
Signal & Target
BUY
$204.00
Start Price
$88.42
Best Price (1Y)
$151.18
Current Price
$108.81
Return
+23.1%
Rhythm Pharmaceuticals Inc.
RYTM
Dec 12, 2025
Signal & Target
BUY
$141.00
Start Price
$117.52
Best Price (1Y)
$119.58
Current Price
$89.70
Return
-23.7%
Palvella Therapeutics, Inc.
PVLA
May 16, 2025
Signal & Target
BUY
$52.00
Start Price
$22.05
Best Price (1Y)
$151.18
Current Price
$108.81
Return
+393.5%
Arcturus Therapeutics Holdings Inc
ARCT
Nov 11, 2024
Signal & Target
BUY
$74.00
Start Price
$3.02
Best Price (1Y)
$24.08
Current Price
$7.33
Return
+142.7%
Rocket Pharmaceuticals Inc
RCKT
Nov 11, 2024
Signal & Target
BUY
$39.00
Start Price
$17.09
Best Price (1Y)
$17.83
Current Price
$2.86
Return
-83.3%
Alnylam Pharmaceuticals Inc
ALNY
Oct 24, 2024
Signal & Target
BUY
$336.00
Start Price
$294.87
Best Price (1Y)
$495.55
Current Price
$287.80
Return
-2.4%
Vertex Pharmaceuticals, Inc.
VRTX
Oct 22, 2024
Signal & Target
SELL
$361.00
Start Price
$478.09
Best Price (1Y)
$362.50
Current Price
$450.69
Return
+5.7%
Alnylam Pharmaceuticals Inc
ALNY
Oct 01, 2024
Signal & Target
BUY
$366.00
Start Price
$273.69
Best Price (1Y)
$484.21
Current Price
$287.80
Return
+5.2%
Rocket Pharmaceuticals Inc
RCKT
Sep 18, 2024
Signal & Target
BUY
$38.00
Start Price
$21.80
Best Price (1Y)
$22.00
Current Price
$2.86
Return
-86.9%
Arcturus Therapeutics Holdings Inc
ARCT
Aug 06, 2024
Signal & Target
BUY
$72.00
Start Price
$3.20
Best Price (1Y)
$25.88
Current Price
$7.33
Return
+129.1%
Signal & Target
BUY
$93.00
Start Price
$80.47
Best Price (1Y)
$94.85
Current Price
$55.65
Return
-30.8%
Alnylam Pharmaceuticals Inc
ALNY
Jul 08, 2024
Signal & Target
BUY
$357.00
Start Price
$253.86
Best Price (1Y)
$333.70
Current Price
$287.80
Return
+13.4%
Ultragenyx Pharmaceutical Inc.
RARE
May 31, 2024
Signal & Target
BUY
$111.00
Start Price
$38.65
Best Price (1Y)
$60.37
Current Price
$25.38
Return
-34.3%
Arcturus Therapeutics Holdings Inc
ARCT
May 10, 2024
Signal & Target
BUY
$86.00
Start Price
$3.83
Best Price (1Y)
$25.88
Current Price
$7.33
Return
+91.4%